Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis

Head and Neck Oncology

Volumn 2, Issue 1, 2010, Pages

  Sarkis, Seta A ^a   Abdullah, Bashar H ^a   Abdul Majeed, Ban A ^a   Talabani, Nazar G ^b  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b UNIVERSITY OF SULAIMANI   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY D2-40; PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION; BIOSYNTHESIS; CELL GROWTH; ENZYMOLOGY; MIDDLE AGED; MOUTH TUMOR; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROGNOSIS; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL GROWTH PROCESSES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77954970908     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-2-13     Document Type: Article

References (27)

1. Robbins Basic Pathology. V Kumar RS Cotran SL Robbins Neoplasia V Kumar RS Cotran SL Robbins editors, Saunders, Philadelphia Seventh edition. 2003
2. Tumor Markers. S Eissa S Shoman, Hodder Arnold Publication 1998
3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. TJ Lynch DW Bell R Sordella S Gurubhagavatula RA Okimoto BW Brannigan PL Harris SM Haserlat JG Supko FG Haluska DN Louis DC Christiani J Settleman DA Haber, NEJM 2004 350 21 2129 2139 10.1056/NEJMoa040938 15118073
4. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: A TMA-based immunohistochemical analysis. K Laimer G Spizzo G Gastl P Obrist Th Brunhuber D Fong V Barbieri S Jank W Doppler M Rasse B Norer, Oral Oncology 2007 43 193 198 10.1016/j.oraloncology.2006.02.009 16854613
5. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. ZJ Shang JR Li, J Oral Pathology & Medicine 2005 34 3 134 10.1111/j.1600-0714.2004.00259.x (Pubitemid 40293221)
6. The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma. S Johnstone RM Logan, Oral Oncology 2006 42 4 337 342 10.1016/j.oraloncology.2005.06.020 16144770
7. Expression of vascular endothelial growth factor in patients with testicular germ cell tumor as an indicator of metastatic disease. S Fukuda T Shirahama Y Imazono, Cancer 1999 85 1323 1330 10.1002/(SICI)1097-0142(19990315) 85:6<1323::AID-CNCR15>3.0.CO;2-G 10189138
8. Angiogenesis: Now and then. C Costa R Soares F Schmitt, APMIS 2004 112 402 416 10.1111/j.1600-0463.2004.apm11207-0802.x 15563305
9. Sequential increases in proliferative cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker. DM Shin N Vararud JY Ro, J Natl Cancer Inst 1993 85 971 978 10.1093/jnci/85.12.971 8098774
10. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma. LF Wang CY Chai WR Kuo CF Tai KW Lee KY Ho, Am J of Otolaryngology 2006 27 101 105 10.1016/j.amjoto.2005.07.018 (Pubitemid 43267274)
11. Cell proliferation. P Hall, Journal of Pathology 1991 165 349 354 10.1002/path.1711650412 1783954
12. The p53 network in head and neck cancer. M Gasco T Crook, Oral Oncology 2003 39 222 231 10.1016/S1368-8375(02)00163-X 12618194
13. Lymphangiogenesis and tumor metastasis. MS Pepper, Clinical Cancer Research 2001 7 462 468 11297234
14. Lymphangiogenesis lymphedema and cancer. The role of tumor lymphangiogenesis in metastatic spread. S Stacker M Baldwin M Achen, The FASEB Journ 2002 16 922 934 10.1096/fj.01-0945rev (Pubitemid 34753498)
15. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumors. FA Alves FR Pires OP de Almeida MA Lopes LP Kowalski, Int J Oral Maxillofac Surg 2004 10 593 597 10.1016/j.ijom.2004.01.010 (Pubitemid 39145184)
16. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to P53, Ki-67 and prognosis. J Lim S Kang M Lee H Pai J Lee S Hong,, et al. J Oral Pathol Med 2003 32 552 561 10.1034/j.1600-0714. 2003.00145.x 12969230 (Pubitemid 37175008)
17. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Y Hiraishi T Wada K Nakatani K Negoro S Fujita, Pathology Oncology Research 2006 12 2 10.1007/BF02893450 16799709
18. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumors from both metastatic clear cell renal cell carcinoma and phaeochromocytoma. L Browning D Bailey A Parker, Journal of Clinical Pathology 2008 61 293 296 10.1136/jcp.2007.049544 17660332
19. Dysadherin expression in head and neck squamous cell carcinoma association with lymphangiogenesis and prognostic significance. PA Kyzas D Stefanou A Batistatou NJ Agnantis Y Nakanishi S Hirohashi,, et al. Am J Surg Pathol 2006 30 2 185 193 10.1097/01.pas.0000178090.54147.f8 16434892
20. Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinoma. ME Christensen MH Therkildsen BL Hansen H Albeck GN Hensen P Bretlau, Eur Arch Otorhinolaryngol 1992 249 5 243 7 10.1007/BF00714485 1524803
21. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. T Krcicki M Jele M Zalesska-Krcicka J Rak T Szkudlarek J Jele-Krcicka, Oral Oncology 1999 35 180 186 10.1016/S1368-8375(98)00100-6 10435153
22. C-erb B recepotrs in squamous cell carcinomas of the head and neck clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors. P O- charoenrat PH Rhys-Evans DJ Archer SA Bccles, Oral Oncolgy 2002 10 1
23. Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma. H Sakai K Kawano N Hishimoto, J Oral Pathol Med 1990 19 1 4 10.1111/j.1600-0714.1990.tb00773.x 2179534
24. VEGF-C is associated with lymphatic status and invasion in oral cancer. BSMS Siriwardena Y Kudo I Ogawa MNGPK Udagama WM Tilakaratne T Takata, J Clin Pathol 2008 61 103 108 10.1136/jcp.2007.047662 17351086
25. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early- stage squamous cell carcinoma of the uterine cervix. Z Gombos X Xu CS Chu PJ Zhang G Acs, Clinical Cancer Research 2005 11 8364 8371 10.1158/1078-0432.CCR-05-1238 16322297
26. Predictive value of P53 and PCNA expression for occult neck metastases in patients with clinically node negative oral tongue cancer. KC Keum EJ Chung WS Koom JH Cho SH Cho EC Choi CG Lee CO Suh GE Kim, Otolaryngology 2006 135 6 858 864
27. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. E Lieto F Ferraraccio M Orditura P Castellano AL Mura M Pinto A Zamboli F DeVita G Galizia, Ann Surg Oncol 2008 15 1 69 79 10.1245/s10434-007-9596-0 17896140